Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03436381 · ClinicalTrials.gov registry record
Can Sleep Apnea Screening Questionnaire Predict Adverse Events in Endoscopic Studies
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 350
- Enrollment target
NCT03436381 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 350 participants.
The verdict
NCT03436381 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
Study Summary
Investigators hypothesize that the obese population (BMI ≥30 kg/m2) who might be at higher risk for obstructive sleep apnea (OSA), carries a higher risk of endoscopy associated adverse events. The primary aim of our study is to determine predictors of endoscopy associated adverse events (airway maneuvers and sedation related complications) in the obese population including the use of the STOP-BANG questionnaire (SBQ) and Epworth Sleepiness Scale (ESS). A secondary aim is to determine the impact of referral to sleep medicine clinic and home sleep test ordered from the gastroenterologist if patient was found to be high risk for OSA by the use of validated questionnaires such as SBQ and ESS.
Interventions
- OTHER Questionaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2018-02-09 |
| Est. Completion | 2021-12-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03436381
The ClinicalTrials.gov registry entry for NCT03436381 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionaire is the first listed.
NCT03436381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03436381 about?
NCT03436381 is a clinical study titled "Can Sleep Apnea Screening Questionnaire Predict Adverse Events in Endoscopic Studies". Investigators hypothesize that the obese population (BMI ≥30 kg/m2) who might be at higher risk for obstructive sleep apnea (OSA), carries a higher risk of endoscopy associated adverse events. The primary aim of our study is to determine predictors of endoscopy associated adverse events (airway mane...
What is the current status of trial NCT03436381?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2018-02-09. Estimated completion is 2021-12-18.
What interventions are being tested in trial NCT03436381?
The interventions under investigation include: Questionaire (OTHER).
Who is sponsoring clinical trial NCT03436381?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.